-
Assessment of Willingness and Influencing Factors for COVID-19 Booster Vaccination Among Residents of Hong Kong in the Post-Pandemic Context
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insights From a Real-World Retrospective Study
Mar 10, 2025, 14:00 PM -
Is Poor Adherence to Good Modeling Practices Making Us Worry Too Much About Effect Modifiers? A Case Study in Moderate to Severe Plaque Psoriasis
Mar 10, 2025, 14:00 PM -
A German Claims Database Analysis of Epidemiology, Treatment Patterns, and Healthcare Resource Utilization of Patients with Primary Biliary Cholangitis (PBC)
Mar 10, 2025, 14:00 PM -
Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer
Mar 10, 2025, 14:00 PM -
Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study
Mar 10, 2025, 14:00 PM -
Patient- and Observer-Reported Outcomes with Therapeutic Medical Devices in Children and Adolescents with Obesity: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Software as a Medical Device: Current Regulations in North America and Europe
Mar 10, 2025, 14:00 PM -
Is there a GLP-1 Halo Effect? Potentially Better Overall Health Management Due to Starting GLP-1 for Weight Loss
Mar 10, 2025, 14:00 PM -
Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?
Mar 10, 2025, 14:00 PM -
Patient-Centric Factors in AI Chatbot Adoption for Healthcare
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns of First-Line (1L) Ibrutinib in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): Insights into Therapy Interruptions, Discontinuation and Next Treatment
Mar 10, 2025, 14:00 PM -
Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Mar 10, 2025, 14:00 PM -
Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists
Mar 10, 2025, 14:00 PM -
Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC .
Mar 10, 2025, 14:00 PM -
A Comparative Assessment of LLM Agreement for Clinical Data Extraction Tasks
Mar 10, 2025, 14:00 PM -
Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach
Mar 10, 2025, 14:00 PM -
NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study
Mar 10, 2025, 14:00 PM
